Showing results (1791-1800 of 1,886) with videos related to
Sort By:
Pageof 189
Nature Communications|February 23, 2023
TEFM variants impair mitochondrial transcription causing childhood-onset neurological diseaseLindsey Van Haute, Emily O'Connor, Héctor Díaz-Maldonado, et al.Blood|April 7, 2021
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemiasRachel Thijssen, Sarah T Diepstraten, Donia Moujalled, et al.Genome Medicine|May 21, 2025
Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseasesDaniella H Hock, Nikeisha J Caruana, Liana N Semcesen, et al.Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.American Journal of Primatology|March 23, 2026
A Collaborative, Multi-Institutional Growth Standard for Dam-Reared Infant Rhesus and Pigtail Macaques (Macaca mulatta and Macaca nemestrina) in Research SettingsAndrew J Haertel, Kathryn E Berns, Kathrine Shelley P Falkenstein, et al.American Journal of Human Genetics|September 2, 2022
Genetic structure correlates with ethnolinguistic diversity in eastern and southern AfricaElizabeth G Atkinson, Shareefa Dalvie, Yakov Pichkar, et al.Biorxiv : the Preprint Server for Biology|November 3, 2022
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaquesTimothy N Hoang, Elise G Viox, Amit A Upadhyay, et al.Journal of Medicinal Chemistry|May 18, 2021
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous RouteStepan Vyskocil, David Cardin, Jeffrey Ciavarri, et al.American Journal of Human Genetics|March 26, 2021
Low-coverage sequencing cost-effectively detects known and novel variation in underrepresented populationsAlicia R Martin, Elizabeth G Atkinson, Sinéad B Chapman, et al.Journal of Medicinal Chemistry|November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.Pageof 189